ENO1 and neoplasm: The study provided evidence that Hsp90 inhibition could block the marginal colocalization of Hsp90, ENO1, and PKM2 in tumor cells (Figure 5I and Figure S5E, Supporting Information), moving colocalization closer to the perinuclear region and restoring their uniform distribution in the cytoplasm.